Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
DNLI

Denali Therapeutics

$23.56

0.05 (0.21%)

17:10
05/08/19
05/08
17:10
05/08/19
17:10
Earnings
Denali Therapeutics reports Q1 EPS (41c), consensus (40c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

Over a month ago
DNLI

Denali Therapeutics

$24.10

-0.74 (-2.98%)

13:25
04/23/19
04/23
13:25
04/23/19
13:25
Conference/Events
Denali Therapeutics participates in a conference call with JPMorgan »

SMid Biotech Analyst Fye…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

DNLI

Denali Therapeutics

$24.84

-0.32 (-1.27%)

04:55
04/23/19
04/23
04:55
04/23/19
04:55
Conference/Events
Denali Therapeutics participates in a conference call with JPMorgan »

SMid Biotech Analyst Fye…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

DNLI

Denali Therapeutics

$26.21

-0.57 (-2.13%)

12:08
04/17/19
04/17
12:08
04/17/19
12:08
Conference/Events
Denali Therapeutics participates in a conference call with JPMorgan »

SMid Biotech Analyst Fye…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNLI

Denali Therapeutics

$24.26

2.04 (9.18%)

13:58
03/13/19
03/13
13:58
03/13/19
13:58
Syndicate
Breaking Syndicate news story on Denali Therapeutics »

Denali Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNLI

Denali Therapeutics

$21.73

1.08 (5.23%)

09:07
03/12/19
03/12
09:07
03/12/19
09:07
Earnings
Denali Therapeutics reports Q4 EPS 79c, may not compare to consensus (11c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Mar

DNLI

Denali Therapeutics

$21.90

-0.35 (-1.57%)

06:17
02/28/19
02/28
06:17
02/28/19
06:17
Hot Stocks
Denali Therapeutics, AbCellera announce expanded collaboration »

AbCellera announced an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
DNLI

Denali Therapeutics

$21.44

-0.16 (-0.74%)

12:03
02/20/19
02/20
12:03
02/20/19
12:03
Hot Stocks
Denali granted orphan status for mucopolysaccharidosis treatment »

The FDA granted Denali…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DNLI

Denali Therapeutics

$20.25

0.28 (1.40%)

, SNY

Sanofi

$41.57

-0.06 (-0.14%)

09:05
02/15/19
02/15
09:05
02/15/19
09:05
Hot Stocks
Denali Therapeutics, Sanofi announce initiation of dosing for DNL747 »

Denali Therapeutics…

DNLI

Denali Therapeutics

$20.25

0.28 (1.40%)

SNY

Sanofi

$41.57

-0.06 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

  • 11

    Mar

  • 22

    Mar

  • 28

    Apr

CTMX

CytomX Therapeutics

$19.05

-0.01 (-0.05%)

, DNLI

Denali Therapeutics

$19.16

0.51 (2.73%)

08:14
02/05/19
02/05
08:14
02/05/19
08:14
Hot Stocks
CytomX Therapeutics announces Nick Galli as CBO »

CytomX Therapeutics…

CTMX

CytomX Therapeutics

$19.05

-0.01 (-0.05%)

DNLI

Denali Therapeutics

$19.16

0.51 (2.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.